Replies to post #230717 on Anavex Life Sciences Corp (AVXL)

[JWC3]

The advent of approvals of A 2-73 will bring the entire status quo of the Alzheimer testing regime into question.

It won’t be the same after approvals.

The whole BIIB bully bit will be out the door.

And then AVXL can actually pay money for a trial for A 2-73 on MS!

After that:

The whole BIIB bit will be out the door!